A0596 Circulating CD44⁺/CD133⁺ cancer stem cell signatures as liquid biopsy biomarkers in Castration-Resistant metastatic Prostate Cancer (CRPC)

European Urology 2026

View at publisher

Authors: P. Verma

DOI: 10.1016/s0302-2838(26)00647-0

Cited by: 0

Fields of Study & Subjects

Prostate Cancer Treatment and Research Cancer Cells and Metastasis Cancer Genomics and Diagnostics